HanchorBio is preparing to advance HCB303 into its Phase 1 first-in-human, dose-escalation study (HCB303-ONC-101; NCT07859228 ...

Learn about the common side effects of targeted therapies for advanced basal cell carcinoma and effective strategies to ...

The human face is one of the most complex structures formed during embryonic development. Its formation requires different cell populations to produce ...

Objective Response Rate (ORR) in 69 Patients with Non-Squamous mNSCLC, Consistent with Previously Reported Results IOV-LUN-202 Cohorts 1 and 2 Are Completing Enrollment and Support a Planned ...

Artiva Biotherapeutics permanently discontinues AlloNK, its lead NK cell therapy, after a patient dies of fludarabine-linked ...

A closer look at Reviralis Complete's brand-stated vitamin, mineral, and botanical formula, advertised pricing, and 60-day ...

A Nigerian government investigative panel has concluded that 37 suspected illegal miners died in detention last month ...

A peer-reviewed review proposes that chronic DNA damage response signaling may connect senescence, inflammation and other ...

Researchers from R3 Medical Research and R3 Stem Cell have published a peer-reviewed narrative review on Arthritis in ...

SpaceX’s effort to turn Starlink Mobile into the US’s fourth major carrier might involve it buying access to tens of ...

A review finds that HIV-1 suppresses MAVS-dependent antiviral signaling in myeloid cells while distinct IFI16 and CARD8 pathways can promote inflammasome activation in other cellular contexts.

Single-cell digital twins connect in vitro drug screening studies with clinical outcomes, providing a new framework to evaluate therapies and advance precision medicine in pregnancy.